Filing Details
- Accession Number:
- 0001209191-16-108297
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-03-14 20:41:41
- Reporting Period:
- 2016-03-10
- Filing Date:
- 2016-03-14
- Accepted Time:
- 2016-03-14 20:41:41
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1169987 | Htg Molecular Diagnostics Inc | HTGM | Laboratory Analytical Instruments (3826) | 860912294 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1623587 | L John Lubniewski | C/O Htg Molecular Diagnostics, Inc. 3430 E. Global Loop Tucson AZ 85706 | Chief Business Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2016-03-10 | 1,512 | $2.49 | 31,200 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2016-03-11 | 5,264 | $2.36 | 25,936 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2016-03-14 | 113 | $2.19 | 25,823 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- Sale of shares of common stock under an existing Rule 10b5-1 Plan to cover tax withholding obligations incurred in connection with the issuance of shares of common stock to the Reporting Person on March 4, 2016 under the Issuer's annual incentive plan. The Issuer's annual incentive plan provides that performance-based bonuses may be paid in cash or shares of common stock, or a combination of both, at the discretion of the Issuer's board of directors.
- The weighted average sale price for the transaction reported was $2.4903, and the range of prices were between $2.35 and $2.69. Upon request by the SEC staff, the Issuer, or any securityholder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
- The weighted average sale price for the transaction reported was $2.3554, and the range of prices were between $2.1810 and $2.5900. Upon request by the SEC staff, the Issuer, or any securityholder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
- The weighted average sale price for the transaction reported was $2.1865, and the range of prices were between $2.1800 and $2.2000. Upon request by the SEC staff, the Issuer, or any securityholder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
Billionaire Hedge Funds
